(Q35917341)

11 August 2017

1 reference

title

Malaria chemoprophylaxis: when should we use it and what are the options? (English)

1 reference

11 August 2017

0 references

1

Eskild Petersen

1 reference

11 August 2017

publication date

1 February 2004

1 reference

Expert Review of Anti-infective Therapy

11 August 2017

published in

1 reference

11 August 2017

volume

2

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

119-132

1 reference

Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

The risk of malaria in travellers to Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Retrospective evaluation of exposure to P. falciparum using antibodies to circumsporozoite protein and to cultured P. falciparum antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

The efficacy of pyrimethamine-sulfadoxine (Fansidar) in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Resistance to pyrimethamine/sulfadoxine in Plasmodium falciparum in 12 villages in north east Tanzania and a test of chlorproguanil/dapsone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Efficacy of daily antimalarial chemoprophylaxis in tropical Africa using either doxycycline or chloroquine-proguanil; a study conducted in 1996 in the French Army

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Mefloquine or doxycycline prophylaxis in US troops in Somalia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxycycline, and chloroquine plus proguanil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Plasma concentrations of sulfadoxine-pyrimethamine and of mefloquine during regular long term malaria prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Mefloquine-induced psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

User Acceptability Patterns for Mefloquine and Doxycycline Malaria Chemoprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Primaquine as prophylaxis for malaria for nonimmune travelers: A comparison with mefloquine and doxycycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Comparison of tafenoquine (WR238605) and primaquine in the post-exposure (terminal) prophylaxis of vivax malaria in Australian Defence Force personnel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

The suppression of malarial parasitaemia by pyrimethamine in combination with dapsone or sulphormethoxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Long-term malaria prophylaxis with weekly mefloquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Prevention and morbidity of malaria in non-immune subjects; a case-control study among Italian troops in Somalia and Mozambique, 1992-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Malaria disaster in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Causal prophylactic efficacy of atovaquone-proguanil (Malarone) in a human challenge model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Time to reappearance of malaria parasites following various drug treatment regimens in a holoendemic area of western Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Atovaquone plus proguanil is an effective treatment for Plasmodium ovale and P. malariae malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, west Africa. 6. The impact of the interventions on mortality and morbidity from malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Hyperpigmented dermal macules in children following the administration of Maloprim for malaria chemoprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Chlorproguanil/dapsone for the treatment of non-severe Plasmodium falciparum malaria in Kenya: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

The effects of inadvertent exposure of mefloquine chemoprophylaxis on pregnancy outcomes and infants of US Army servicewomen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

The effects of mefloquine treatment in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

The chemotherapy of rodent malaria. LXI. Drug combinations to impede the selection of drug resistance, part 4: the potential role of 8-aminoquinolines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

Neurologic reactions after a therapeutic dose of mefloquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

PLASMODIUM VIVAX CHESSON STRAIN

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.119

21 January 2018

Identifiers

DOI

10.1586/14787210.2.1.119

1 reference

11 August 2017

1 reference